Delivery Order SPE2DB22D1002-SPE2DB25FLFN9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $37,159 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose) pen injectors in 3ml quantities. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $33,160.61 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL), with completion targeted for August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate office and...
- The Defense Logistics Agency awarded a delivery order valued at $10,550.33 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose pen, 3 mL) with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,266.60 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $14,466.50 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract, which is not set aside for any specific category, represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was competitively awarded and will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $5,768.41 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml), with performance completion required by July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $1,136.92. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order valued at $41,688.44 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). This firm fixed-price delivery order is set to be completed by August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded, non-set-aside contract for pharmaceutical products supporting federal medical procurement needs. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,554.18 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose) pen injectors in 3 mL formulations. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025, without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $11,020.09 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3ml) with an ultimate completion date of July 28, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFN9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,460.02 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose) pen injectors in 3mL quantities. This is a firm fixed price delivery order with a completion deadline of July 31, 2025, awarded on July 30, 2025. The award is not set-aside and represents a competitive procurement for pharmaceutical supplies to support federal medical needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen leverages this prime contract vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialized medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 7/30/25 |